(29) found that serum markers, such as CRP and LDH, combined with the level of elevated serum B-cell activating factor (BAFF), reflect the severity of lung injury and contribute to the early identification of RP-ILD in IIM patients. This evidence concerns the gene TNFSF13B and interstitial lung disease.